• Теги
    • избранные теги
    • Компании2234
      • Показать ещё
      Разное681
      • Показать ещё
      Международные организации53
      • Показать ещё
      Страны / Регионы539
      • Показать ещё
      Показатели33
      • Показать ещё
      Люди96
      • Показать ещё
      Издания55
      • Показать ещё
      Формат38
17 сентября, 05:30

Aggregating global biotech resources

MANY factors that shape preeminent cities can be found in the field of biotech. It is a game-changing industry that leads the next round of global competition. It helps advance city development through

15 сентября, 17:55

Oncology Space in Focus this Week on ESMO Presentations

  • 0

There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca's lung cancer study data was positive and so was Bristol-Myers's melanoma candidate.

15 сентября, 17:33

Amgen/Allergan's Avastin Biosimilar Secures FDA Approval

The FDA approves Amgen-Allergan's biosimilar version of Roche's Avastin for treating multiple types of cancers, to be marketed by the trade name of Mvasi.

15 сентября, 16:34

Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE

Bristol-Myers Squibb Company (BMY) enters into a collaboration and license agreement with Halozyme Therapeutics, Inc. (HALO).

15 сентября, 15:31

Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%

Halozyme Therapeutics (HALO) was a big mover last session, as the company saw its shares rise more than 21% on the day amid huge volumes.

Выбор редакции
15 сентября, 11:54

La Roche-Posay предложил поглотить кожное сало

Косметический бренд La Roche-Posay выпустил очищающую матирующую маску для лица в гамме Effaclar. Средство предназначено для ухода за жирной проблемной кожей. Отмечается, что она «абсорбирует излишки кожного сала, удаляет даже невидимые глазу загрязнения кожи и глубоко очищает поры.

Выбор редакции
14 сентября, 22:05

Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
Выбор редакции
14 сентября, 12:00

World XI memories, Merckx makes history and a Perisic pearler | Classic YouTube

This week’s roundup also features an ambulance gone awry, the greatest bowl in the history of bowls and a college football calamity1) The UCI road world championships begin this week in Bergen. The last time the championships were held Scandinavia was 2011, when Mark Cavendish raced through the streets of Copenhagen to become the first British winner of the men’s road race since Tom Simpson in 1965 (footage of that win in a drenched San Sebastian can be found at 4min 53sec here). Chris Froome is in the British squad for the time trial but the route means he will not attempt to win the historic Triple Crown of two grand tours and the world road race title, a feat only twice before achieved in the history of cycling: by Eddy Merckx in Montreal in 1974 and Stephen Roche in Villach, Austria, in 1987.2) Ivan Perisic shows Manchester United what they’re missing with this thunderbolt for Internazionale against Spal. Wahab Khazri shows Sunderland what they never really got to see at the Stadium of Light with this cheeky flick for Rennes against Marseille. And Billy Ions’ effort for SJK against VPS wasn’t bad either. Continue reading...

14 сентября, 06:08

The $417 Million Baby Powder Lawsuit and 15 Other Infamous Personal Injury Cases

From the infamous hot coffee lawsuit to the case of a risky acne drug, here are 15 times when companies had to pay for selling dangerous products.

Выбор редакции
14 сентября, 01:08

Roche (RHHBY) Announces Data on Respiratory Drug Esbriet

Roche Holdings AG (RHHBY) announced results from a six-month study combining idiopathic pulmonary fibrosis (IPF) drug Esbriet (pirfenidone) and Ofev.

14 сентября, 01:08

Roche (RHHBY) Announces Data on Respiratory Drug Esbriet

Roche Holdings AG (RHHBY) announced results from a six-month study combining idiopathic pulmonary fibrosis (IPF) drug Esbriet (pirfenidone) and Ofev.

13 сентября, 18:32

Nektar (NKTR) Starts PROPEL Combo Study for Cancer Candidate

Nektar (NKTR) initiates phase I/II combo study on lead candidate NKTR-214 along with Tecentriq and Keytruda. The trial complements Nektar's ongoing PIVOT research clubbed with Opdivo.

13 сентября, 17:47

Array's NDAs for Melanoma Combo Accepted for Review by FDA

Array BioPharma's (ARRY) new drug applications for the combination of binimetinib and encorafenib to treat melanoma, accepted for review by the FDA.

13 сентября, 15:33

Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data

  • 0

Key highlights include Alexion's (ALXN) restructuring plans and promising data from Kura Oncology on its lead pipeline candidate.

12 сентября, 18:27

Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA

  • 0

Novartis AG (NVS) announced that the FDA accepted its Biologics License Application for a proposed biosimilar version of Roche Holding AG's (RHHBY) Rituxan.

11 сентября, 19:01

Drugs help fight cancer at ‘an earlier stage’

Cancer doctors are widening the net for immunotherapy, a new class of drugs that enlist the body’s defenses in the fight against tumors.

Выбор редакции
Выбор редакции
11 сентября, 16:42

Roche's Ophthalmology Drug Fails to Meet Primary Endpoint

Roche's (RHHBY) share price declined after its ophthalmology candidate, lampalizumab, failed to meet the primary endpoint in phase III Spectri study.

11 сентября, 16:42

Roche's Ophthalmology Drug Fails to Meet Primary Endpoint

Roche's (RHHBY) share price declined after its ophthalmology candidate, lampalizumab, failed to meet the primary endpoint in phase III Spectri study.